USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
LaserGen, Inc.
Address:
8052 El Rio Street
Houston, TX
Phone:
(713) 747-3380
URL:
EIN:
470848632
DUNS:
106700375
Number of Employees:
9
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $725,461.00 4
STTR Phase I $633,757.00 2

Award List:

Synthesis of Fluorobase Nucleotides for DNA Sequencing

Award Year / Program / Phase:
2003 / SBIR / Phase I
Award Amount:
$213,064.00
Agency:
HHS
Principal Investigator:
Mathew Mahindaratne
Abstract:
DESCRIPTION (provided by applicant): The introduction of novel fluorescent dyes has significantly impacted DNA sequencing technologies by improving accuracy and read lengths, increasing throughput, and decreasing costs. Despite these advances, however, sequencing reactions labeled by dye-terminator… More

Development of Novel Fluorescent Dyes for DNA Sequencing

Award Year / Program / Phase:
2003 / SBIR / Phase I
Award Amount:
$214,000.00
Agency:
HHS
Principal Investigator:
Matthew Mahindaratne
Abstract:
DESCRIPTION (provided by applicant): The introduction of novel fluorescent dyes has significantly impacted DNA sequencing technologies by improving accuracy and read lengths, increasing throughput, and decreasing costs. Despite these advances, however, sequencing reactions labeled by dye-terminator… More

Fluorescent, Photolabile Terminators for DNA Sequencing

Award Year / Program / Phase:
2004 / SBIR / Phase I
Award Amount:
$148,397.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): New methods for sequencing genornic DNA rapidly and accurately in a large number of individuals are needed to better understand the role of genetic variation in common disease. Sequencing-by-synthesis (SBS) is one of the most promising contemporary methods for… More

Feasibility Study to Explore NGS technologies for Pathogen Identification

Award Year / Program / Phase:
2012 / SBIR / Phase I
Award Amount:
$150,000.00
Agency:
DOD
Principal Investigator:
David Hertzog, VP Business Development – (713) 747-3380
Abstract:
Pathogen detection involving microbial forensics is an emerging field that presents enormous challenges for both the scientific and legal communities. Microbial pathogens of humans represent a highly diverse set of organisms known to cause disease and death. Microbes have also developed a number… More